SUSMED Co., Ltd. announced a private placement for gross proceeds of ¥720,000,000 on June 4, 2018. The transaction included participation from new investors Tokyo Century Corporation (TSE:8439), M3, Inc. (TSE:2413), SBI Investment Co., Ltd., Sony Innovation Fund, The Dai-Ichi Life Insurance Company, Limited, and existing investor Beyond Next Ventures Inc. The company issued shares through a third party allocation method.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
578 JPY | +0.87% | +0.52% | -56.70% |
2023 | SUSMED,Inc.(TSE:4263) added to S&P Global BMI Index | CI |
2022 | Walgreens Boots Alliance, Inc. Joins Sustainable Medicines Partnership | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,502 JPY | -0.73% | -6.74% | 6.48B | ||
1,448 JPY | +0.59% | -1.46% | 4.5B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.70% | 61.45M | |
-18.30% | 180B | |
+1.02% | 166B | |
+3.46% | 155B | |
+4.14% | 99.3B | |
+50.96% | 93.8B | |
+14.41% | 84.11B | |
-3.50% | 73.81B | |
-2.39% | 46.39B | |
-36.10% | 42.58B |
- Stock Market
- Equities
- 4263 Stock
- News SUSMED,Inc.
- SUSMED Co., Ltd. announced that it has received ¥720 million in funding from Tokyo Century Corporation, M3, Inc., SBI Investment Co., Ltd., Beyond Next Ventures Inc., Sony Innovation Fund, The Dai-Ichi Life Insurance Company, Limited